Gabapentin Capsule
Product Images NDC 70518-2970

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 70518-2970). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Gabapentin is a medication with NDC #70518-2970-00. The package contains 30 capsules of 300 mg manufactured by ScieGen Pharmaceuticals, Inc. from Hauppauge, NY. The LOT number and expiration date are not available. The medication should be kept out of children's reach, and the package insert should be consulted for use. The medicine should be stored at 20-26°C (63-77°F) and can have excursions permitted of 15-30°C (59-86°F). The medication is RX only and was repackaged by RemedyRepack Inc. in Indiana, PA.*

FDA Label Image

Figure 1 (Image 01)

FDA Label Image

Figure 2 (Image 02)

This is a chart showing the mean pain score during a 4-week fixed dose period of gabapentin at 1800mg/day and 2400mg/day compared to a placebo. The x-axis shows the baseline and weeks 1-7 of the study.*

FDA Label Image

Figure 3 (Image 03)

FDA Label Image

Cockcroft And Gault Equation (Image 04)

FDA Label Image

Gabapentin Structural Formula (Image 05)

FDA Label Image

Figure 4. Responder Rate In Patients Receiving Gabapentin Expressed As A Difference From Placebo By Dose And Study: Adjunctive Therapy Studies In Patients ≥12 Years Of Age With Partial Seizures (Image 09)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.